Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

108.35
+0.05000.05%
Post-market: 108.350.00000.00%16:46 EDT
Volume:627.44K
Turnover:68.31M
Market Cap:5.35B
PE:-18.78
High:109.64
Open:108.36
Low:107.34
Close:108.30
Loading ...
Nov 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 16, 2021

Major Issues Report

Axsome Therapeutics, Inc.
Sep 16, 2021

Major Issues Report

8-K - Current report
Sep 14, 2021

Major Issues Report

Axsome Therapeutics, Inc.
Sep 14, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 26, 2021

Major Issues Report

8-K - Current report